Literature DB >> 27738357

Monoarthritis Induced by Bupropion Hydrochloride.

Weiqing Yuan1, Barry N Williams1.   

Abstract

Bupropion hydrochloride is an inhibitor of dopamine and norepinephrine, which is commonly prescribed for major depression, smoking cessation, and bipolar depression. Here we report a highly unusual case of bupropion induced knee monoarthritis in a bipolar depression patient. With bupropion XL 150 mg for 2 weeks, her left knee began to swell; at the third week, this condition was worsening. The aggravation of the left knee effusion stopped after the discontinuation of bupropion XL. The effusion and swelling disappeared after 15 ml of synovial fluid was drawn out and the effusion has never returned. Analysis of the synovial fluid showed noninflammatory effusion. Her left knee swelling was most likely due to angioedema caused by bupropion XL.

Entities:  

Keywords:  Angioedema; Bupropion hydrochloride; Knee; Major Depression; Monoarthritis; Side effects

Year:  2011        PMID: 27738357      PMCID: PMC5044482     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  5 in total

1.  Pediatric bupropion-induced serum sicknesslike reaction.

Authors:  Sabine Hack
Journal:  J Child Adolesc Psychopharmacol       Date:  2004       Impact factor: 2.576

2.  Joint symptoms in patients on bupropion therapy.

Authors:  Paul Ornetti; Anne Disson-Dautriche; Géraldine Muller; Anne Cherasse; Christian Tavernier; Jean-François Besancenot; Catherine Sgro; Jean-Francis Maillefert
Journal:  Joint Bone Spine       Date:  2004-11       Impact factor: 4.929

Review 3.  Bupropion extended-release for depressive disorders.

Authors:  James W Jefferson
Journal:  Expert Rev Neurother       Date:  2008-05       Impact factor: 4.618

Review 4.  Bupropion: a review of its use in the management of major depressive disorder.

Authors:  Sohita Dhillon; Lily P H Yang; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Bupropion-induced angioedema.

Authors:  Amy E Tackett; Kelly M Smith
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

  5 in total
  1 in total

1.  Revisiting bupropion anti-inflammatory action: involvement of the TLR2/TLR4 and JAK2/STAT3.

Authors:  Alireza Karimollah; Anahid Hemmatpur; Taha Vahid
Journal:  Inflammopharmacology       Date:  2021-07-03       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.